JP Morgan Chase’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-112
Closed -$3.24K 7767
2025
Q4
$3.24K Sell
112
-5,996
-98% -$114K ﹤0.01% 6875
2025
Q3
$47.4K Buy
6,108
+904
+17% +$6.78K ﹤0.01% 6253
2025
Q2
$38.5K Buy
5,204
+3,176
+157% +$27.9K ﹤0.01% 6010
2025
Q1
$17.5K Sell
2,028
-99,350
-98% -$1.53M ﹤0.01% 6188
2024
Q4
$3.62M Buy
101,378
+7,324
+8% +$379K ﹤0.01% 3649
2024
Q3
$4.44M Buy
94,054
+14,978
+19% +$661K ﹤0.01% 3301
2024
Q2
$3.97M Buy
79,076
+21,982
+39% +$1.59M ﹤0.01% 3221
2024
Q1
$6.39M Buy
57,094
+53,941
+1,711% +$5.36M ﹤0.01% 2877
2023
Q4
$183K Sell
3,153
-7,528
-70% -$303K ﹤0.01% 5432
2023
Q3
$339K Sell
10,681
-47,071
-82% -$2.24M ﹤0.01% 4724
2023
Q2
$4.75M Buy
57,752
+52,889
+1,088% +$7.74M ﹤0.01% 2912
2023
Q1
$500K Sell
4,863
-10,610
-69% -$1.49M ﹤0.01% 4505
2022
Q4
$2.27M Buy
15,473
+13,068
+543% +$2.21M ﹤0.01% 3470
2022
Q3
$406K Sell
2,405
-15,641
-87% -$2.54M ﹤0.01% 4585
2022
Q2
$2.08M Buy
18,046
+5,661
+46% +$532K ﹤0.01% 3512
2022
Q1
$1.24M Buy
12,385
+11,122
+881% +$1.3M ﹤0.01% 4115
2021
Q4
$197K Buy
1,263
+2
+0.2% +$389 ﹤0.01% 5370
2021
Q3
$297K Buy
1,261
+67
+6% +$19.6K ﹤0.01% 5024
2021
Q2
$405K Sell
1,194
-4,493
-79% -$1.7M ﹤0.01% 4826
2021
Q1
$2.3M Sell
5,687
-1,273
-18% -$617K ﹤0.01% 3616
2020
Q4
$4.63M Sell
6,960
-1,335
-16% -$742K ﹤0.01% 2871
2020
Q3
$3.89M Sell
8,295
-705
-8% -$356K ﹤0.01% 2760
2020
Q2
$5.26M Sell
9,000
-8,867
-50% -$3.03M ﹤0.01% 2414
2020
Q1
$2.6M Sell
17,867
-9,263
-34% -$1.62M ﹤0.01% 2766
2019
Q4
$3.89M Sell
27,130
-10,027
-27% -$733K ﹤0.01% 2889
2019
Q3
$1.47M Buy
37,157
+4,601
+14% +$335K ﹤0.01% 3608
2019
Q2
$3.32M Sell
32,556
-379
-1% -$44.6K ﹤0.01% 2986
2019
Q1
$4.33M Buy
32,935
+15,944
+94% +$2.01M ﹤0.01% 2696
2018
Q4
$1.73M Buy
16,991
+4,257
+33% +$674K ﹤0.01% 3385
2018
Q3
$3.18M Buy
12,734
+962
+8% +$322K ﹤0.01% 3111
2018
Q2
$5.26M Sell
11,772
-555
-5% -$244K ﹤0.01% 2650
2018
Q1
$4.86M Sell
12,327
-1,020
-8% -$403K ﹤0.01% 2601
2017
Q4
$5.48M Sell
13,347
-67
-0.5% -$29.2K ﹤0.01% 2614
2017
Q3
$5.86M Sell
13,414
-227
-2% -$89.5K ﹤0.01% 2441
2017
Q2
$4.76M Buy
+13,641
New +$4.72M ﹤0.01% 2507

Other funds holding MRSN